Home›People›Neil Thapar
Neil Thapar

Neil Thapar

Executive officer at Barricade Therapeutics.

Executive
Updated Nov 10, 2026·Latest SEC filing Jun 10, 2026·Suggest an edit

About Neil Thapar

Neil Thapar is an executive officer at Barricade Therapeutics.

Experience

This experience comes from Neil Thapar's profile and from SEC filings. For roles taken from filings, the years are when the filings name Neil Thapar in the role, so the role may have started earlier or lasted longer.

Barricade Therapeutics Corp Current
CEO / CSO
2017 – Present · Fort Worth, TX
Develops an experimental oral treatment for people with colorectal cancer.
Drug Development-2-Clinic Consulting, LLC
Consultant
2013 – 2021
ESSA Pharmaceuticals
Director, Clinical Pharmacology
2015 – 2017
Claria Biosciences
VP Drug Metabolism & Pharmacokinetics
2012 – 2013
Reata Pharmaceuticals
Director, Drug Metabolism and Pharmacokinetics
2006 – 2012
MD Anderson Cancer Center
Clinical Pharmacology Research Specialist
2004 – 2006

Sources

  1. SECBarricade Therapeutics Corp Form D, filed Jun 10, 2026